Nasdaq: TGTX
TG Therapeutics insiders
The officers, directors and 10% owners of TG Therapeutics, Inc. who hold the most stock, valued at the live TGTX price.
$64.88
TGTX today −$1.2M (−1.88%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 7
- Their TGTX stock
- $748M
- Market value
- $9.81B
- Held by ranked insiders
- 7.63%
Insiders by value of TGTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Michael S. Weiss | CEO | 9,778,086 | $634M | 6.47% | 393rd |
| 2 | Sean A. Power | CFO | 798,111 | $51.8M | 0.53% | 2483rd |
| 3 | Kenneth Hoberman | Director | 279,653 | $18.1M | 0.19% | 4909th |
| 4 | Yann Echelard | Director | 223,816 | $14.5M | 0.15% | 6611th |
| 5 | Daniel Hume | Director | 192,748 | $12.5M | 0.13% | 7411th |
| 6 | Laurence N. Charney | Director | 168,640 | $10.9M | 0.11% | 8042nd |
| 7 | Sagar Lonial | Director | 94,061 | $6.1M | <0.1% | 12615th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for TG Therapeutics; see each profile for the filing.